Innovation for Kidney Disease

Nephrology and urology clinical trials include diverse patient populations with complex diagnoses and comorbidities, which can bring with them both high costs and patient recruitment shortfalls. Familiarity with finding and managing these patients is key to study management as well as site selection.

At Clinipace, we understand the unique challenges of nephrology and urology studies and know how to simplify and streamline your experience with a collaborative team, consortia partnerships, and state-of-the-art technology.

Learn more about our nephrology and urology study capabilities and experience below:

Study Capabilities and Experience

  • Acute kidney injury
  • Chronic kidney failure
    • Diabetic kidney disease
    • Autoimmune diseases, including lupus nephritis
    • Glomerulonephritis
    • Polycystic kidney disease, autosomal dominant
  • End stage renal disease
    • Hemodialysis
    • Peritoneal dialysis
    • Anemia of CKD, including iron supplements and erythropoiesis-stimulating agents
    • Renal bone disease and secondary hyperparathyroidism, including phosphate binding agents, calcimimetics, and vitamin D analogues
    • Arterial calcification
    • Hemodialysis access, including catheter lock solutions
  • Renal cell carcinoma
  • Transplantation, including immunosuppressive therapy
  • Other orphan diseases, including:
    • Lysosomal storage diseases
    • Fabry disease
    • Adrenal gland neoplasms
    • Scleroderma
    • Renal artery obstruction